Allergan, Inc. v. Alcon Laboratories, Inc.

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

• explaining that “[r]isk factors for glaucoma have 1 traditionally included people with diabetes [and] high blood pressure”
• “Infringement actions under Section 271(e)(2) must therefore be limited to the Controlling Use Patents,” which that court defined as “all use patents which claim an indication for the drug which the applicant is seeking approval.”

Source: CourtListener parenthetical corpus (CC0).